Adherence of gastroenterologists to European Crohn's and Colitis Organisation Consensus on Crohn's disease: A real-life survey in Spain

Journal of Crohn's and Colitis

Volumn 6, Issue 7, 2012, Pages 763-770

  Hinojosa, J ^a   Gisbert, J P ^b   Gomollon F ^c   Lopez San Roman A ^d  

^a HOSPITAL DE MANISES   (Spain)

^b Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Crohn's disease; ECCO clinical guidelines; Inflammatory bowel disease; Questionnaire

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; METHOTREXATE;

ANESTHESIA; ARTICLE; CLINICAL PRACTICE; CONSENSUS; CROHN DISEASE; DISEASE CLASSIFICATION; DRUG INDICATION; FOLLOW UP; HEALTH SURVEY; HUMAN; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SPAIN; SURGICAL APPROACH; SURGICAL TECHNIQUE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; AZATHIOPRINE; CROHN DISEASE; GASTROENTEROLOGY; GLUCOCORTICOIDS; GUIDELINE ADHERENCE; HEPATITIS B; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA, HUMAN; METHOTREXATE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; SPAIN; SPECIALIZATION; VACCINATION;

EID: 84863470478     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.12.013     Document Type: Article

References (25)

1. Jess T., Riis L., Vind I., Winther K.V., Borg S., Binder V., et al. Changes in clinical characteristics, course and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007, 13:481-489.
2. Economou M., Pappas G. New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008, 14:709-720.
3. Lopez-Serrano P., Perez-Calle J.L., Carrera-Alonso E., et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig 2009, 101:768-772.
4. Castro M., Papadatou B., Baldassare M., et al. Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003). Inflamm Bowel Dis 2008, 14:1246-1252.
5. Wilson J., Hair C., Knight R., et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis 2010, 16:1550-1556.
6. Baumgart D.C., Bernstein C.N., Abbas Z., et al. IBD around the world: comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 - inflammatory bowel disease task force meeting. Inflamm Bowel Dis 2011, 17:639-644.
7. Yu A.P., Cabanilla L.A., Wu E.Q., et al. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin 2008, 24:319-328.
8. Odes S. How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol 2008, 14:6641-6647.
9. Mesterton J., Jonsson L., Almer S.H., et al. Resource use and societal costs for Crohn's disease in Sweden. Inflamm Bowel Dis 2009, 15:1882-1890.
10. Michetti P., Stelle M., Juillerat P., et al. Appropriateness of therapy for active Crohn's disease: results of a multidisciplinary international expert panel-EPACT II. J Crohns Colitis 2009, 3:232-240.
11. Tremaine W.J., Sandborn W.J., Loftus E.V., et al. A prospective cohort study of practice guidelines in inflammatory bowel disease. Am J Gastroenterol 2001, 96:2401-2406.
12. Grimshaw J.M., Russell I.T. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993, 342:1317-1322.
13. Pieper C., Haag S., Gesenhues S., et al. Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders-an evaluation study. BMC Health Serv Res 2009, 9:17.
14. Dignass A., Van Assche G., Lindsay J., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010, 4:28-62.
15. Van Assche G., Dignass A., Panes J., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4:7-27.
16. Van Assche G., Dignass A., Reinisch W., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010, 4:63-101.
17. Gagliardi A.R., Brouwers M.C., Palda V.A., et al. How can we improve guideline use? A conceptual framework of implementability. Implementation Science 2011, 6:1-11.
18. Gisbert J.P., Gomollon F., Hinojosa J., et al. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain. J Crohns Colitis 2010, 4:567-574.
19. Keane J., Gershon S., Wise R.P., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
20. Fidder H., Schnitzler F., Ferrante M., et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut 2009, 58:501-508.
21. Gisbert J.P., Chaparro M., Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:619-633.
22. Wagnon J.H., Leiman D.A., Ayers G.D., et al. Survey of gastroenterologists' awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: are the guidelines being used and what are the barriers to their use?. Inflamm Bowel Dis 2009, 15:1082-1089.
23. Reddy S.I., Friedman S., Telford J.J., et al. Are patients with inflammatory bowel disease receiving optimal care?. Am J Gastroenterol 2005, 100:1357-1361.
24. Feakins R.M. An audit of UK pathologists' use of the British Society of Gastroenterology guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. J Clin Pathol 2007, 60:1178-1179.
25. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282:1458-1465.